NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap initiative host NanoWeek 2009

NewsGuard 100/100 Score

The NIH Nanotechnology Task Force and the NIH Nanomedicine Roadmap Initiative will host NanoWeek 2009 from Tuesday, April 7 through Friday, April 10 at the Natcher Conference Center on the NIH campus in Bethesda, Md. NIH's first-of-a-kind series of events focusing on science at the nanoscale, NanoWeek 2009 will include symposia with experts in the field, demonstrations, talks, and posters from NIH scientists.

NanoWeek 2009's first day will include seminars explaining the basic concepts of nanotechnology, followed by summaries of current research being conducted and medical applications of nanotechnology. Speakers include:

  • Dr. Michael Gottesman, deputy director of Intramural Research at the National Institutes of Health
  • Dr. Richard Fisher, associate director for Science Policy and Legislation at the National Eye Institute
  • Dr. Catherine Lewis, director, Division of Cell Biology and Biophysics at the National Institute of General Medical Sciences
  • Dr. Piotr Grodzinski, director of the Nanotechnology in Cancer Program at the National Cancer Institute,
  • Dr. Karen Peterson, senior advisor to the Director of the National Institute of Biomedical Imaging and Bioengineering will also provide remarks.

On Wednesday, NIH scientists will discuss ongoing nanotechnology research being performed at the NIH, along with more than 30 posters presenting work from NIH's labs. There will be afternoon tours of nanotechnology labs at the National Heart, Lung, and Blood Institute, the National Cancer Institute, the National Institute of Arthritis and Musculoskeletal and Skin Diseases, the National Institute of Biomedical Imaging and Bioengineering, and the National Institute of Neurological Disorders and Stroke.

In coordination with IEEE, a leading professional association for the advancement of technology, NIH will conduct a workshop on Nanomedicine on Thursday and Friday. This will provide an opportunity for engineers and physical scientists to exhibit their cutting-edge technology, as well as to learn about possible biological applications for these technologies. Regulatory and intellectual property aspects of nanoresearch will also be addressed, in combination with presentations from some of the major industry efforts in the field.

Events on Tuesday and Wednesday are open to the public and free of charge. Registration for the lab tours will open on April 1. The nanomedicine workshop on Thursday and Friday requires registration, which is located at https://roan2.wustl.edu/. The full week's agenda, as well as further information on NanoWeek 2009, can be found at http://www.capconcorp.com/nanoweek2009/. For more information on nanotechnology at the National Institutes of Health, see the Web site http://www.nibib.nih.gov/Research/NIHNano.

The National Institute of Biomedical Imaging and Bioengineering (NIBIB), a component of the National Institutes of Health, U.S. Department of Health and Human Services, is dedicated to improving human health through the integration of the physical and biological sciences. The research agenda of the NIBIB will dramatically advance the Nation's health by improving the detection, management, understanding, and ultimately, the prevention of disease.

Comments

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Researchers introduce a pioneering approach to combat neurodegenerative diseases